ALGA3

Live / Allowed — Notice of allowance issued (as of 16 Dec 2025)

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 15 May 2024 filing date already counts against anyone who files later.

Record

Serial number
98552476
Mark type
Stylized text
Filed
15 May 2024
Published for opposition
21 Oct 2025
Attorney of record
Peter J. Phillips

Goods and services

  • Class 005 — Pharmaceuticals: Pharmaceutical, medical and veterinary preparations for the treatment and prevention of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders, pharmaceutical products for the prevention and treatment of cancer, pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines, and chemical reagents for medical or veterinary purposes, chemical reagents for medical or veterinary purposes medicines and natural remedies, namely medicinal oils and antiallergic medicines, medicinal preparations for the treatment of infectious diseases and for use in oncology, medicinal drinks, medicinal preparations for infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders, for the prevention and treatment of cancer, for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, for the treatment of epilepsy, pain, anxiety, depression, sleep disorders, parkisons disease, nausea and vomiting, food disorders, arthritis, PTSD, schizophrenia, opioid addiction, alleviate ALS symptoms, multiple sclerosis, and for the treatment of diabetes, natural remedy preparations for the treatment of gastro-intestinal conditions, hormonal and chemical imbalances, and sleep disorders; dietetic preparations adapted for medical purposes and food supplements; Dietary supplements and dietetic preparations adapted for medical purposes; Extracts from medicinal plants other than essential oils, for medicinal purposes
  • Class 029 — Meats and processed foods: Edible oils and fats; dietetic oils and fats, whether or not as intermediate products for industrial use; oils and fats for the manufacture of edible oils and fats

Owner

Prosecution history

  • 16 Dec 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
  • 21 Oct 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 21 Oct 2025 — PUBLISHED FOR OPPOSITION
  • 15 Oct 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 19 Sept 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 18 Sept 2025 — EXAMINER'S AMENDMENT ENTERED
  • 18 Sept 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
  • 18 Sept 2025 — EXAMINERS AMENDMENT E-MAILED
  • 18 Sept 2025 — EXAMINERS AMENDMENT -WRITTEN
  • 30 Apr 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 21 Apr 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 21 Apr 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
  • 22 Jan 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
  • 22 Jan 2025 — NON-FINAL ACTION E-MAILED
  • 22 Jan 2025 — NON-FINAL ACTION WRITTEN

View this trademark record on Marksy